$38.0 Million
Novan, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$37.4 Million
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$57.5 Million
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$30.0 Million
Fulgent Genetics, Inc.
Follow-On Offering
Left Bookrunner
$385.0 Million
Renewable Energy Group, Inc.
Confidentially Marketed Follow-On Offering
Co-Manager
$139.4 Million
Point Biopharmaa Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$201.8 Million
Oak Street Health, LLC
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$53.0 Million
VectivBio Holding AG
Confidentially Marketed Follow-On Offering
Active Bookrunner
$48.0 Million
Lexicon Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.5 Million
Poseida Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Subscribe to CMFO

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.